Interview with Dr. Thomas Costa of Coventya
By Humatica
In the new episode of the alpha Talks Podcast, Enno Krey speaks to Dr. Thomas Costa, former CEO of Coventya (acquired by MacDermid Enthone in 2021), a leading international specialty chemicals company. Thomas has successfully led Coventya through 20 years of PE ownership before it was acquired by Element Solutions Inc (NYSE:ESI) this year.
Thomas speaks about his journey and the lessons learnt as a successful Private Equity CEO.
Listen to the podcast:
You can subscribe to the podcast on Spotify:
alpha Talks is the podcast dedicated to Private Equity value growth. Enno speaks to experienced buyout CEOs, operating partners, deal makers and advisors about their experience and lessons-learned in the industry.
Related Insights
AI Risk: The 10 Things Every Board Should Know (and Most Don’t)
Corporate governance has always lagged behind the risks it is meant to manage. Boards develop oversight frameworks for risks after those risks have become embedded…
Read more
The CFO’s AI Imperative: From Efficiency Gain to Strategic Transformation
Finance has always been an early adopter of technology — from double-entry bookkeeping to spreadsheets to ERP to cloud-based analytics. And finance has always been…
Read more
Building the AI-Ready Organisation: Why Technology is the Easiest Part
When most organisations begin an AI readiness assessment, they start with technology. Do we have a modern cloud infrastructure? A unified data platform? Access to…
Read more
Abonnieren Sie unseren monatlichen Newsletter und andere News Updates
Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität
